SUDOSCAN COMBINED TO OTHER DIAGNOSIS TESTS TO CONFIRM SMALL FIBER NEUROPATHY V. Fabry, A. Gerdelat, B. Acket, P. Cintas, V. Rousseau, E. Uro-Coste, S.
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12